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Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with
ribavirin
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Abstract
Hepatitis E virus (HEV) can cause chronic infections in immunocompromised hosts. Viral kinetics in plasma and stools are poorly
understood, particularly during antiviral treatment. Prolonged faecal shedding may be a concern for transmission. We describe HEV kinetics
in an immunocompromised patient with prolonged faecal shedding despite undetectable viraemia on ribavirin treatment.
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